Dr. Jan Ryszkowski, MD

Dr. Ryszkowski practices at Baptist Health Medical Center-North Little Rock in North Little Rock, Arkansas, part of Baptist Health.

Dr. Ryszkowski's NPI, 1134304512, was assigned on January 4, 2008. Dr. Ryszkowski holds Arkansas license E-5892.

Dr. Ryszkowski's primary practice is Baptist Health Medical Center-North Little Rock, at 3333 Springhill Drive, North Little Rock, AR 72117 in Pulaski County. The practice phone is (501) 202-3000.

Dr. Ryszkowski's primary practice is Baptist Health Medical Center-North Little Rock in North Little Rock, Arkansas, part of Baptist Health. Dr. Ryszkowski is also affiliated with Baptist Health Medical Center-Little Rock. The medical group on file is ARcare. Dmand AI also links Dr. Ryszkowski to 1 more hospital, 1 community health center, 1 physician office, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ryszkowski practices, 6 sites in all. Vendor and product names are available with a free account.

Nuclear medicine is Dr. Ryszkowski's primary specialty in the NPI Registry, under taxonomy code 207U00000X. Dmand AI has Dr. Ryszkowski's licenses on file in 2 states: Arkansas and Michigan.

CMS data shows 2,762 Medicare services from Dr. Ryszkowski across 9 procedure codes in 2024, for 242 Medicare patients. Medicare paid $114,894 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 242 Medicare patients who saw Dr. Ryszkowski in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 3.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ryszkowski's median patient age at 70, with 49% women.

In 2024, Dr. Ryszkowski wrote 562 Medicare Part D claims for 198 patients. 92% of them were for generic drugs. CMS names the drug for 466 of them, across 13 drugs with 11 or more claims each, at $23,998 in total drug cost. In 2023, CMS named 441 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Ryszkowski for performance year 2024, reported individually. Dr. Ryszkowski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 361 procedures of removal of tissue by Dr. Ryszkowski, more than 95% of the clinicians it reports for that procedure.

CMS Open Payments shows 100 general payments to Dr. Ryszkowski from 21 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Paratek Pharmaceuticals, Inc. paid the most, $489.